<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/690ECCF2-F290-4AE0-82CC-F5507E8EDC7E"><gtr:id>690ECCF2-F290-4AE0-82CC-F5507E8EDC7E</gtr:id><gtr:name>Agency for Science, Technology and Research (A*STAR)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F"><gtr:id>9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F</gtr:id><gtr:name>University of Bradford</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Biomedical Science</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/690ECCF2-F290-4AE0-82CC-F5507E8EDC7E"><gtr:id>690ECCF2-F290-4AE0-82CC-F5507E8EDC7E</gtr:id><gtr:name>Agency for Science, Technology and Research (A*STAR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F"><gtr:id>9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F</gtr:id><gtr:name>University of Bradford</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8CD1B7E2-1334-4C4F-9501-7800CCA18B87"><gtr:id>8CD1B7E2-1334-4C4F-9501-7800CCA18B87</gtr:id><gtr:firstName>Peter Walter</gtr:firstName><gtr:surname>Andrews</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700785"><gtr:id>CFA6BBB9-978F-4B9E-9041-994B92EB20EB</gtr:id><gtr:title>Culture Adaptation in Human Embryonic Stem Cell Lines</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700785</gtr:grantReference><gtr:abstractText>Human embryonic stem (ES) cells offer considerable opportunities for regenerative medicine, drug discovery and toxicology. To realise this potential, a detailed understanding of their basic biology is required. It has become evident over the past three to four years that human ES cells may undergo genetic and other changes that may enhance their capacity for growth in culture, when they are maintained for extended periods. We have called this process, ?culture adaptation?. The underlying hypothesis of this proposal is that the mechanisms affected during culture adaptation of ES cells are those that control the balance between self renewal, differentiation and death of these pluripotent stem cells. Understanding the basis for adaptation may not only provide a rational basis for designing improved methods to culture these cells while minimising the appearance of variants, but also may provide insights into the processes that control the self renewal of pluripotent stem cells and suggest approaches for controlling their growth and differentiation. Further, an understanding of culture adaptation of ES cells may provide insights into the mechanisms that drive progression of teratocarcinomas, a rare tumour of young men, but also a paradigm for other stem cell based malignancies.</gtr:abstractText><gtr:technicalSummary>Human embryonic stem (ES) cells may undergo karyotypic changes upon prolonged culture. These genetic changes often accompany phenotypic changes that render the cells more robust and easier to maintain, a phenomenon termed ?culture adaptation?. This phenomenon is complex and may include alterations in cell fate decisions, as well as changes in proliferation rate, cloning efficiency, and the phenotype of cells with respect to specific markers, differentiation capacity and malignant potential. The karyotypic changes associated with adaptation are non-random, with acquisition of extra copies of chromosomes 17, 12 and X being especially common. These changes parallel similar genomic amplifications in embryonal carcinoma (EC) cells, a cancer counterpart of ES cells, which highlights the potential link of culture adaptation in ES cells to the development of a malignant phenotype. However, little is known about the factors that drive culture adaptation, nor the cellular and genetic mechanisms involved. Nevertheless, the appearance of such adaptive changes in human ES cells is likely to have a substantial impact upon their eventual application, whether in regenerative medicine or drug discovery and toxicology. In this project we will first define the features that characterise the culture adapted phenotype of human ES cells and the extent to which these features occur independently or in a co-ordinated fashion. We will then seek to determine the nature of the selective pressures that drive the appearance of variant ES cells and to establish how interaction of the different features of the culture adapted phenotype with culture and passage conditions provide cells with a selective advantage. Finally we will aim to identify in more detail the specific genetic changes and individual genes that contribute to the culture adapted phenotype of human ES cells.</gtr:technicalSummary><gtr:fund><gtr:end>2013-10-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1384105</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agency for Science, Technology and Research (A*STAR)</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:description>Joint PhD Studentship with A Star, Singapore</gtr:description><gtr:id>893ACAE4-800C-4B9B-A555-694BFBA98743</gtr:id><gtr:impact>Paper in preparation</gtr:impact><gtr:outcomeId>WiZJam2fSLN-1</gtr:outcomeId><gtr:partnerContribution>Preparation and analysis of variant hESC lines, expressing genes from a minimal amplicon on chromosome 20q.</gtr:partnerContribution><gtr:piContribution>Analysis of karyotype of variant hESC and analysis of data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bradford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences Bradford</gtr:department><gtr:description>Nuclear organisation and structure of hES cells.</gtr:description><gtr:id>99481E84-FB89-4B70-AEEC-A11A160BAB54</gtr:id><gtr:impact>Ongoing.</gtr:impact><gtr:outcomeId>RLoR5mZABQ3-1</gtr:outcomeId><gtr:partnerContribution>Sharing of technical expertise. Talk given to this group.</gtr:partnerContribution><gtr:piContribution>Provision of human ES cells for analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Continuation of collaboration with The Radium Hospital, Oslo</gtr:description><gtr:id>759891E5-5892-48C4-8CD6-2BBE62C15B25</gtr:id><gtr:impact>Manuscript in preparation.</gtr:impact><gtr:outcomeId>TTPCyHwXbqg-1</gtr:outcomeId><gtr:partnerContribution>Transcriptional analysis of human ES cells and humn EC cells.</gtr:partnerContribution><gtr:piContribution>Exchange of culture techniques in growing human ES cells, growth and sorting of human ES and EC cells. Transfer of cells from this group to Oslo to allow them to analyse gene expression.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ESTOOLS Public Meeting, Rome</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B3257037-7A08-42D6-AE87-C43EC3FCE021</gtr:id><gtr:impact>Public meeting open to lay public, journalists and policy makers as well as scientists

Contributed to discussion in Italy about research with human ES cells</gtr:impact><gtr:outcomeId>99A0C481011</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ESTOOLS public meeting, Lisbon</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5D6D55E7-89E3-4535-B1F8-0E4BBA995737</gtr:id><gtr:impact>300 delegates were brought together at the final ESTOOLS annual meeting. In addition, there was a theatre event open to members of the public which generated interest, questions and debate in the use of human embryonic stem cell research within Europe.

Unknown.</gtr:impact><gtr:outcomeId>gyKQxNB9kHz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Researchers Night</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>46C1AF2D-22E9-411B-9769-09D44B869DE4</gtr:id><gtr:impact>A night to attract and engage the public in the work of the Centre for Stem Cell Biology. Attended by over 200 members of the public. A range of activities were offered; including screenings of short films, informative posters, interactive games and practical demonstrations.

Excellent feedback received back from the vast majority of attendees. Will write a blog describing the event for Eurostemcell who provided some of the outreach materials.</gtr:impact><gtr:outcomeId>pPNj5Eptw3b</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>41E380BD-6E33-47A6-828D-2CD96A10D5AE</gtr:id><gtr:title>Identification of Novel Fusion Genes in Testicular Germ Cell Tumors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a0b101026bcb88354d570bb7c9132a1"><gtr:id>8a0b101026bcb88354d570bb7c9132a1</gtr:id><gtr:otherNames>Hoff AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>58aef812a1ce68.48028159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B8C847A-29C6-47A6-B232-EC04D8E47636</gtr:id><gtr:title>Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d92a9285cfc8833d0021abd991d5fdc"><gtr:id>5d92a9285cfc8833d0021abd991d5fdc</gtr:id><gtr:otherNames>Desmarais JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_12423_23_22553144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36F6E758-C020-42B9-81CC-7726384269A5</gtr:id><gtr:title>Modeling the evolution of culture-adapted human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bf29cc64cc3ad1da2149cdaa69f4766"><gtr:id>2bf29cc64cc3ad1da2149cdaa69f4766</gtr:id><gtr:otherNames>Olariu V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>F8FF39DE4BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA705AE8-71C2-4353-9FEF-1EF2345FD6FE</gtr:id><gtr:title>CD30 expression reveals that culture adaptation of human embryonic stem cells can occur through differing routes.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/467dd9e4f7722a91db698430bf7fbaef"><gtr:id>467dd9e4f7722a91db698430bf7fbaef</gtr:id><gtr:otherNames>Harrison NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>8F797A263A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED338C08-A27E-4BA9-8545-00E32A21D6BD</gtr:id><gtr:title>High-throughput karyotyping of human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51783269b827096303a4d966fa221bc4"><gtr:id>51783269b827096303a4d966fa221bc4</gtr:id><gtr:otherNames>Lund RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>pm_12423_23_22877823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B45CD5E-5947-409B-80E2-BDE79AECA48B</gtr:id><gtr:title>Surface marker antigens in the characterization of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c0469fc5dc00695f27e3bbc4f71be88"><gtr:id>9c0469fc5dc00695f27e3bbc4f71be88</gtr:id><gtr:otherNames>Wright AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>BD69428B3CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C6015E-1CDE-41F5-9B23-ED426454BD59</gtr:id><gtr:title>Human embryonic stem cells: 10 years on.</gtr:title><gtr:parentPublicationTitle>Laboratory investigation; a journal of technical methods and pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8de61945ea18be25d2b84a5c863ba79"><gtr:id>d8de61945ea18be25d2b84a5c863ba79</gtr:id><gtr:otherNames>Gokhale PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0023-6837</gtr:issn><gtr:outcomeId>pm_12423_13_19153556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CEFC9DD-6519-4A9A-BDC4-4F5291699CF3</gtr:id><gtr:title>PAX4 enhances beta-cell differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d35b264e78cb1334ae29357e5f8511b"><gtr:id>2d35b264e78cb1334ae29357e5f8511b</gtr:id><gtr:otherNames>Liew CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>8F90311030F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62DC0F66-8966-4E32-A775-95AD759788A7</gtr:id><gtr:title>Nuclear proteome dynamics in differentiating embryonic carcinoma (NTERA-2) cells.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/018d66289e040d6796a87af47fd9f000"><gtr:id>018d66289e040d6796a87af47fd9f000</gtr:id><gtr:otherNames>Pewsey E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>pm_12423_23_20459141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55AA5E7A-3585-4BF5-982C-789BA169A9EB</gtr:id><gtr:title>Culture adaptation alters transcriptional hierarchies among single human embryonic stem cells reflecting altered patterns of differentiation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8de61945ea18be25d2b84a5c863ba79"><gtr:id>d8de61945ea18be25d2b84a5c863ba79</gtr:id><gtr:otherNames>Gokhale PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56bc6180ad5c83.21660944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51C39776-95D0-4681-AA90-C0175D933F7F</gtr:id><gtr:title>Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e11db96000c3052be9f9b8cf3b9d9dbd"><gtr:id>e11db96000c3052be9f9b8cf3b9d9dbd</gtr:id><gtr:otherNames>Ben-David U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56bc60132ab3d8.86960898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D3DE587-3201-4C93-AB85-FC1DBF1AF4F9</gtr:id><gtr:title>Stem cell states, fates, and the rules of attraction.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa5e23ae3b15b0a7aff6b72b42090ed2"><gtr:id>aa5e23ae3b15b0a7aff6b72b42090ed2</gtr:id><gtr:otherNames>Enver T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>DC939C9BBC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EFFC708-8188-4344-9F6E-B4AC4EE91D34</gtr:id><gtr:title>High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c8b2fa7273856740f1dd6f4597cda0b"><gtr:id>8c8b2fa7273856740f1dd6f4597cda0b</gtr:id><gtr:otherNames>N?rv? E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>T6L2MD5LQYt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>388D264E-0BDC-45B7-AE70-016528046C38</gtr:id><gtr:title>High-content screening for chemical modulators of embryonal carcinoma cell differentiation and survival.</gtr:title><gtr:parentPublicationTitle>Journal of biomolecular screening</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3794ab5d3cad9801078c60433623947"><gtr:id>a3794ab5d3cad9801078c60433623947</gtr:id><gtr:otherNames>Barbaric I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0571</gtr:issn><gtr:outcomeId>pm_5435a9f5a9f8551d1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3722026B-50EE-44A7-B3B0-486E975C6ADC</gtr:id><gtr:title>Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner.</gtr:title><gtr:parentPublicationTitle>Differentiation; research in biological diversity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4838e2dca2e68726eefdfc5cce14c1f"><gtr:id>d4838e2dca2e68726eefdfc5cce14c1f</gtr:id><gtr:otherNames>Tonge PD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0301-4681</gtr:issn><gtr:outcomeId>V9TzKAHDDyf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9F021EF-59F5-4665-B66E-6A9D44941666</gtr:id><gtr:title>Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness.</gtr:title><gtr:parentPublicationTitle>Nature nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ddde182fec90e5e9d7df46ca9ed6d6f"><gtr:id>6ddde182fec90e5e9d7df46ca9ed6d6f</gtr:id><gtr:otherNames>Sood A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1748-3387</gtr:issn><gtr:outcomeId>pm_5435aad5aadca149a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACF29992-BFC8-4E91-927C-080F6D3B020F</gtr:id><gtr:title>Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77053460c769d143610c0c1399cb41a2"><gtr:id>77053460c769d143610c0c1399cb41a2</gtr:id><gtr:otherNames>Alagaratnam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>pm_12423_23_23137282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2681752F-66EA-47AF-B77F-27213425E0F6</gtr:id><gtr:title>Prepatterning in the stem cell compartment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4838e2dca2e68726eefdfc5cce14c1f"><gtr:id>d4838e2dca2e68726eefdfc5cce14c1f</gtr:id><gtr:otherNames>Tonge PD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Zk8Ttw8RPg6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E53E52B-868D-4F9A-9402-C3C4E9CB5244</gtr:id><gtr:title>BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec1ca597b55d8403a4784be82340c57b"><gtr:id>ec1ca597b55d8403a4784be82340c57b</gtr:id><gtr:otherNames>Avery S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5460d5105df0a6.43525796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9DED092-E20D-4CEB-AA73-F473E8F32A79</gtr:id><gtr:title>OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/712b646f22f8b7748126deeab49b3464"><gtr:id>712b646f22f8b7748126deeab49b3464</gtr:id><gtr:otherNames>Atlasi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>9E07543FB8D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4078C3CF-19BB-4D92-95A5-ED2DDF2B8459</gtr:id><gtr:title>Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cff9ba49635dbcd0bce5585c152bb68"><gtr:id>6cff9ba49635dbcd0bce5585c152bb68</gtr:id><gtr:otherNames>Plews JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>nzBFahdS8V8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC9AD5E1-6BA0-4EF3-8359-3E432B9E8014</gtr:id><gtr:title>Inhibition of ERK1/2 prevents neural and mesendodermal differentiation and promotes human embryonic stem cell self-renewal.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b17707820da8c0303ca8ff697aec7f7"><gtr:id>6b17707820da8c0303ca8ff697aec7f7</gtr:id><gtr:otherNames>Na J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>pm_5435aad5aad9ae382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6510C416-7924-4D17-9949-9F248C38B3F1</gtr:id><gtr:title>Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3183d5f9359d778d60996f9b7461936"><gtr:id>d3183d5f9359d778d60996f9b7461936</gtr:id><gtr:otherNames>Sonne SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>8E2006FD77F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA603FCC-DDC7-40C6-B8FB-200612BB0357</gtr:id><gtr:title>Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3794ab5d3cad9801078c60433623947"><gtr:id>a3794ab5d3cad9801078c60433623947</gtr:id><gtr:otherNames>Barbaric I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>A6TaL6Surwo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C18021F8-9DB3-4478-855D-FA773F60F897</gtr:id><gtr:title>High-content screening of small compounds on human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3794ab5d3cad9801078c60433623947"><gtr:id>a3794ab5d3cad9801078c60433623947</gtr:id><gtr:otherNames>Barbaric I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>GEF4wMXEe6N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E178853-9682-4A53-B589-9BDB67B08194</gtr:id><gtr:title>Induced pluripotency enables differentiation of human nullipotent embryonal carcinoma cells N2102Ep.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50bfeb298b756dca7a5bf7aef916046d"><gtr:id>50bfeb298b756dca7a5bf7aef916046d</gtr:id><gtr:otherNames>Sutiwisesak R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56bc60641c2be0.92720018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A25AE40A-6F62-4F6F-B442-9C2A66F59A34</gtr:id><gtr:title>Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3794ab5d3cad9801078c60433623947"><gtr:id>a3794ab5d3cad9801078c60433623947</gtr:id><gtr:otherNames>Barbaric I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5460d59242f478.28354120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3050F6D-FE72-408B-834E-AD3EFFB174D3</gtr:id><gtr:title>Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13336df85d65ae458beb66af5ae249f"><gtr:id>b13336df85d65ae458beb66af5ae249f</gtr:id><gtr:otherNames>Fox V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>iDQ1XbqULib</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B7C80FC-6628-4E87-8ADB-1ABF8BD262D4</gtr:id><gtr:title>Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fb974fd7c306c7ec3a24e09a8a3831c"><gtr:id>8fb974fd7c306c7ec3a24e09a8a3831c</gtr:id><gtr:otherNames>Hyka-Nouspikel N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_12423_23_22821732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AD40DA2-7EB9-4323-9A4C-7778F69EA758</gtr:id><gtr:title>Altered patterns of differentiation in karyotypically abnormal human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22431402f73e1affa6b918d77c825059"><gtr:id>22431402f73e1affa6b918d77c825059</gtr:id><gtr:otherNames>Fazeli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>Jfc4ttVAgv9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1988F175-8F6A-4768-82DD-E3969949CAAC</gtr:id><gtr:title>Restoration of auditory evoked responses by human ES-cell-derived otic progenitors.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699ec640b1c8da6802ba2f100373f8e1"><gtr:id>699ec640b1c8da6802ba2f100373f8e1</gtr:id><gtr:otherNames>Chen W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12423_23_22972191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31A3D59A-B089-4347-AA90-E26EA01CC034</gtr:id><gtr:title>Molecular mechanisms of pluripotency and reprogramming.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b17707820da8c0303ca8ff697aec7f7"><gtr:id>6b17707820da8c0303ca8ff697aec7f7</gtr:id><gtr:otherNames>Na J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>Rmbkk9MPi4v</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D78E6AE-8040-4042-83CA-47CA32D124B5</gtr:id><gtr:title>A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afc5556f40fdc1fd0def7e439bf93fc0"><gtr:id>afc5556f40fdc1fd0def7e439bf93fc0</gtr:id><gtr:otherNames>Hovatta O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>q492GZn2ZDc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F769B9E-5E3D-4891-A40A-310FC16A7AAC</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_12423_23_22119741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0488C54A-D800-4321-A664-BD16B4778E4A</gtr:id><gtr:title>Assessing the safety of stem cell therapeutics.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b32a981511d90997eefade788477b715"><gtr:id>b32a981511d90997eefade788477b715</gtr:id><gtr:otherNames>Goldring CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>Tf5PLLvfw3X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6EB878C-E7CD-4533-AD39-06BA7AEF4F1A</gtr:id><gtr:title>Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5595022016a4a1c3f702d2689191724"><gtr:id>a5595022016a4a1c3f702d2689191724</gtr:id><gtr:otherNames>Furue MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>B0735EEB366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6A7C34E-24E9-4A87-B677-DB8017DD8A1E</gtr:id><gtr:title>Cancer genes hypermethylated in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/653c648f8ba3a9b096ce08aea0614090"><gtr:id>653c648f8ba3a9b096ce08aea0614090</gtr:id><gtr:otherNames>Calvanese V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>FF5845EBA3B</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700785</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>